Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NYSE:PBYI)

59.12
Delayed Data
As of 4:01pm ET
 +1.49 / +2.59%
Today’s Change
19.74
Today|||52-Week Range
107.49
-24.59%
Year-to-Date
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biot...
Aug 19 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug 23 / Zacks.com - Paid Partner Content
4 Biggest Winners from This Earnings Season
Aug 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close57.63
Today’s open58.47
Day’s range56.73 - 59.61
Volume473,938
Average volume (3 months)738,609
Market cap$1.9B
Dividend yield--
Data as of 4:01pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)-57.51%
Earnings growth (this year)-4.56%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.08

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-0.23-0.43%
IPXLImpax Laboratories I...0.000.00%
IRWDIronwood Pharmaceuti...-0.01-0.07%
ITCIIntra-Cellular Thera...+0.32+0.79%
Data as of 4:00pm ET, 08/29/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$1.96
Annual revenue (last year)$0.00
Annual profit (last year)-$239.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs